20 ml of Tirzepatide: Clearing Up a Very Common Confusion

The misconception: that tirzepatide is measured and bought by the millilitre

A lot of online content about tirzepatide (particularly from US sources or grey-market sellers) describes it in millilitres or total vial volumes: 10 ml, 20 ml, 40 ml. That framing comes from the compounding pharmacy model, common in the United States, where tirzepatide peptide is prepared in multi-dose vials and drawn into syringes by the patient or a nurse. In that context, a "20 ml vial" is a real product category.

In the UK, it isn't. Mounjaro is supplied as a pre-filled, single-patient KwikPen. Each pen contains the medicine ready to inject; there is no drawing-up, no vial, no syringe. The dose you receive is described in milligrams (2.5 mg, 5 mg, 7.5 mg and so on up to 15 mg) not in millilitres. If you've seen a UK seller advertising tirzepatide by volume, that is a strong signal the product sits outside the MHRA-authorised supply chain. The Mounjaro page on our site covers what the licensed pen actually looks like and how the titration schedule works.

Compounded tirzepatide has no marketing authorisation in the UK. The MHRA has been explicit that GLP-1 medicines sold without a valid prescription, including through social media or overseas websites, pose real safety risks, fake and unlicensed pens have caused hospitalisations. If the format, the volume description, or the price looks unfamiliar, that unfamiliarity is worth heeding.

What 20 ml actually represents in a compounding context, and why it doesn't translate here

For anyone curious about the underlying pharmacology: tirzepatide is a highly potent peptide. In compounded vials, a typical concentration might be 5 mg/ml or 10 mg/ml, meaning a 20 ml vial could theoretically hold 100–200 mg of the drug. That is a large quantity relative to a single dose, which in the licensed Mounjaro pen ranges from 2.5 mg at the start of treatment to 15 mg at the highest strength. If you've come across listings describing a 40 ml tirzepatide vial, that volume would represent an even larger stockpile of doses, something entirely outside how the medicine is supplied in the UK.

None of this is relevant to how tirzepatide is prescribed or dispensed in the UK. Here, the prescriber selects a dose in milligrams, the pharmacy dispenses the corresponding pre-filled pen, and the patient uses it once weekly at the prescribed strength. There is no patient-facing volume calculation involved. If you've found references to 1 ml tirzepatide or other volume descriptions while researching, the same principle applies: those phrasings belong to a different regulatory and dispensing context than the UK licensed route.

The NHS overview of tirzepatide explains the medicine's mechanism and licensed use clearly, and is worth reading alongside any information you find elsewhere.

How to identify a genuinely licensed UK source for tirzepatide

The practical question most people have after landing here is: where do I actually get this medicine legitimately? The answer has two parts. First, you need a prescription from a qualified prescriber who has assessed your health, BMI, and medical history. Second, that prescription must be dispensed by a pharmacy you can verify.

In the UK, any registered pharmacy (online or physical) appears on the GPhC register, searchable at the General Pharmaceutical Council's register. Checking takes about thirty seconds and is the single most useful thing you can do before handing over personal or payment details to an online service. Red flags include sellers who describe the medicine by volume, such as those advertising a 10 ml tirzepatide vial, which signals a compounding context that has no place in the UK licensed supply chain. Sellers who offer it without any consultation process, or advertise prices that seem remarkably low compared with the typical UK private market, are equally worth treating with caution.

For context on what private tirzepatide treatment genuinely costs in the UK, our weight-loss treatments page sets out what a legitimate prescription service includes. A quick note on timing: if you're weighing this up around payday or a bank holiday, it's worth knowing that orders placed before 12pm on a working day can be dispatched the same day once clinical approval is given.

At nume, every consultation is reviewed personally by a GPhC-registered Independent Prescriber. A real clinician reads your details, not a form-sorting algorithm. You can read more about our clinical team on the clinical team profile page.

Eligibility for tirzepatide under the UK licence

Mounjaro's UK licence covers adults with a BMI of 30 or above, or a BMI of 27 or above alongside at least one weight-related condition such as high blood pressure, type 2 diabetes, high cholesterol, or obstructive sleep apnoea. For some ethnic backgrounds, the clinical threshold sits 2.5 kg/m² lower under UK guidance. BMI alone does not determine suitability, a prescriber weighs the full picture, including any medicines you already take and your medical history.

The medicine is not licensed for people under 18, and it is not recommended during pregnancy, while breastfeeding, or when actively trying to conceive. Anyone with a history of medullary thyroid carcinoma or MEN2 syndrome should discuss this with their GP before seeking a private consultation. If you have seen references to tirzepatide described in units of 20, that is another example of volume or unit framing that reflects compounding practice rather than the milligram dosing used in the UK licensed product. NICE's appraisal of tirzepatide, TA1026, sets out the criteria used by NHS commissioners, useful background even if you're exploring the private route. For a broader look at your options, our weight-loss overview compares the treatments currently available.

If you have questions or want to check whether you're likely to be suitable, speaking to our prescribers is the straightforward next step.